Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

October 09, 2015 11:12 AM ET


Company Overview of Rigel Pharmaceuticals, Inc.

Executive Profile

Stephen A. Sherwin M.D.

Director, Member of Audit Committee and Member of Nominating & Corporate Governance Committee, Rigel Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 7 Board Members in 7 different organizations across 7 different industries.

See Board Relationships


Dr. Stephen A. Sherwin, also known as Steve, M.D., is a Clinical Professor of Medicine at the University of California, San Francisco, and a volunteer Attending Physician in the Hematology/Oncology Division of San Francisco General Hospital. Dr. Sherwin served as Treasurer of Biotechnology Industry Organization. Dr. Sherwin served as the Chief Executive Officer of Cell Genesys Inc. from March 1990 to July 2009. He has more than 30 years of experience in senior leadership ...

Corporate Headquarters

1180 Veterans Boulevard
South San Francisco, California 94080

United States

Phone: 650-624-1100
Fax: 650-624-1101

Board Members Memberships

Independent Director and Member of Audit Committee
Director, Member of Audit Committee and Member of Nominating & Corporate Governance Committee
Independent Director, Member of Science & Technology Committee, Member of Finance Committee and Member of Risk Committee
Director, Member of Compensation Committee and Member of Nominating/Governance Committee
Independent Director and Chairman of Compensation Committee
Member of Scientific Advisory Board and Director


Yale University
Harvard Medical School

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$72,000
Total Calculated Compensation$142,326

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


Harry F. Hixson Jr., Ph.D.Interim Chief Executive Officer, Interim Principal Financial Officer, Independent Director, Chairman of Science Committee and Member of Corporate Governance & Nominating Committee
Arena Pharmaceuticals, Inc.
Paolo Pucci Chief Executive Officer and Director
ArQule Inc.
James A. Bianco M.D.Principal Founder, Chief Executive Officer, President, Executive Director, Member of Scientific Advisory Board and Member of Executive Committee
CTI BioPharma Corp.
Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science & Strategy Committee
Progenics Pharmaceuticals, Inc.
Myung-Joong Cho Ph.D.Founder, Chief Executive Officer and President
CrystalGenomics, Inc.
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Rigel Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at